Top Markets
Coin of the day
Viropro Inc. Viropro Inc.

Viropro Inc.

VPRO
Pozycja w akcjach #41343
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract... Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeutic proteins through the licensing of its proprietary technologies, targeting illnesses like cancer, diabetes, hepatitis, and multiple sclerosis. Viropro manufactures a range of biologics drugs, including biosimilars, for use across all phases of clinical development, from pre-clinical studies through Phase I, II, and III trials. Its offerings to clients include the provision of mammalian cell proteins, such as monoclonal antibodies, recombinant proteins, and other cell-derived compounds. Notably, the firm owns three proprietary clones: two intended for insulin-related therapies and one for cancer treatment. Viropro delivers extensive contractual research and manufacturing solutions to biotech and biopharmaceutical enterprises, performing tasks such as cloning, sequencing, purification, development, validation, and production of biopharmaceutical components and finished products. The company maintains operational presences in Canada, the United Kingdom, and Malaysia, and has established a partnership with Oncobiologics, Inc. for the creation and commercialization of monoclonal antibody products. Viropro Inc. is headquartered in San Jose, California.
Cena akcji
$0.00002
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$25.40K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-80.00%
Kraj
US
Handel Viropro Inc. (VPRO)

Kategoria

Cena VPRO z kapitalizacją rynkową B
Viropro Inc. Viropro Inc.
VPRO
$0.00002
Kapitalizacja rynkowa Viropro Inc.(VPRO)
Kapitalizacja rynkowa: $25.40K
Na dzień August 2026 spółka Viropro Inc. ma kapitalizację rynkową wynoszącą $25.40K. Według naszych danych, czyni to Viropro Inc. 41343rd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Viropro Inc. od 1995 do 2026
VPRO w porównaniu do 5 najpopularniejszych stocks
Cena za VPRO Aktywa B Kapitalizacja rynkowa B Wyniki
Viropro Inc. Viropro Inc.
$4,238.20 $25.40K
$5.383T +21,190,991,318.67%
Viropro Inc. Viropro Inc.
$3,482.44 $25.40K
$4.423T +17,412,183,822.76%
Viropro Inc. Viropro Inc.
$3,275.37 $25.40K
$4.160T +16,376,827,954.96%
Viropro Inc. Viropro Inc.
$2,884.05 $25.40K
$3.663T +14,420,251,974.48%
Viropro Inc. Viropro Inc.
$2,276.20 $25.40K
$2.891T +11,380,998,149.88%